Browse our anti-EGFR (EGFR) Antibodies

Full name:
anti-Epidermal Growth Factor Receptor Antibodies (EGFR)
On www.antibodies-online.com are 2360 Epidermal Growth Factor Receptor (EGFR) Antibodies from 44 different suppliers available. Additionally we are shipping EGFR Kits (145) and EGFR Proteins (136) and many more products for this protein. A total of 2714 EGFR products are currently listed.
Synonyms:
9030024J15Rik, AI552599, C-erb, c-erbB, CG10079, D-Egf, d-egf-r, D-EGFR, dEgfr, dEGFR1, der, DER/EGFR, DER/faint little ball, DER/top, DER/torpedo, DER1, DER flb, Dmel\\CG10079, DmHD-33, EFG-R, Egf, Egf-r, egfr, egfr1, EGFR12, EGFR15, EK2-6, El, Elp, Elp-1, Elp-B1, Elp-B1RB1, Erbb, ErbB-1, ERBB1, Erbb2, Errb1, Errp, flb, HD-33, HER1, l(2)05351, l(2)09261, l(2)57DEFa, l(2)57Ea, l(2)57EFa, mENA, mor1, PIG61, top, top/DER, top/flb, Torpedo/DER, torpedo/egfr, wa-2, wa2, Wa5
list all antibodies Gene Name GeneID UniProt
EGFR 1956 P00533
EGFR 24329  
EGFR 13649 Q01279

Show all species

Show all synonyms

All available anti-EGFR Antibodies

Go to our pre-filtered search.

Top referenced anti-EGFR Antibodies

  1. Human Polyclonal EGFR Primary Antibody for EIA - ABIN358328 : Aifa, Aydin, Nordvall, Lundström, Svensson, Hermanson: A basic peptide within the juxtamembrane region is required for EGF receptor dimerization. in Experimental cell research 2004 (PubMed)
    Show all 5 references for 358328

  2. Human Polyclonal EGFR Primary Antibody for WB - ABIN391933 : Kuribayashi, Kataoka, Kurabayashi, Miura: Evidence that basal activity, but not transactivation, of the epidermal growth factor receptor tyrosine kinase is required for insulin-like growth factor I-induced activation of extracellular signal-regulated kinase in oral carcinoma cells. in Endocrinology 2004 (PubMed)
    Show all 3 references for 391933

  3. Human Polyclonal EGFR Primary Antibody for DB, WB - ABIN389891 : Kapoor, Zhan, Johnson, ORourke: Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells. in Molecular and cellular biology 2003 (PubMed)
    Show all 3 references for 389891

  4. Human Polyclonal EGFR Primary Antibody for ELISA, WB - ABIN1532008 : Ullrich, Coussens, Hayflick, Dull, Gray, Tam, Lee, Yarden, Libermann, Schlessinger: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. in Nature 1984 (PubMed)

  5. Human Polyclonal EGFR Primary Antibody for FACS, IHC (p) - ABIN651628 : Lowenstein, Daly, Batzer, Li, Margolis, Lammers, Ullrich, Skolnik, Bar-Sagi, Schlessinger: The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. in Cell 1992 (PubMed)

  6. Human Monoclonal EGFR Primary Antibody for FACS, IF - ABIN452102 : Wikstrand, Hale, Batra, Hill, Humphrey, Kurpad, McLendon, Moscatello, Pegram, Reist: Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. in Cancer research 1995 (PubMed)

  7. Dog (Canine) Monoclonal EGFR Primary Antibody for EIA, IF - ABIN126767 : Kondo, Higa-Nakamine, Maeda, Toku, Kakinohana, Sugahara, Kukita, Yamamoto: Stimulation of Cell Migration by Flagellin Through the p38 MAP Kinase Pathway in Cultured Intestinal Epithelial Cells. in Journal of cellular biochemistry 2015 (PubMed)

  8. Human Monoclonal EGFR Primary Antibody for IHC (p) - ABIN1687358 : Krager, Sarkar, Twait, Lill, Koland: A novel biotinylated lipid raft reporter for electron microscopic imaging of plasma membrane microdomains. in Journal of lipid research 2012 (PubMed)

More Antibodies against EGFR Interaction Partners

Horse (Equine) Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. Results indicated that most periocular squamous cell carcinomas of horses expressed epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2 (show ERBB2 Antibodies)).

Fruit Fly (Drosophila melanogaster) Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. The activity of Gro (show CXCL1 Antibodies) is antagonized by EGFR signaling, which inhibits Gro (show CXCL1 Antibodies)-dependent repression via p-ERK (show MAPK1 Antibodies) mediated phosphorylation.

  2. These results reveal that ESCRT-0 (ESCRT-0 components stam (show STAM Antibodies) and hrs)mutants inhibit EGFR signaling by disrupting Rhomboid endosomal trafficking in the ligand-producing cells.

  3. we find that EGFR regulates the apical determinant Crb and the extracellular matrix regulator Serp, two factors previously known to control tube length. EGFR regulates the organisation of endosomes in which Crb and Serp proteins are loaded

  4. Here we uncover a cell non-autonomous requirement for the Epidermal growth factor receptor (Egfr) pathway in the lateral epidermis for sustained dpp (show TGFb Antibodies) expression in the LE. Specifically, we demonstrate that Egfr pathway activity in the lateral epidermis prevents expression of the gene scarface (scaf), encoding a secreted antagonist of JNK (show MAPK8 Antibodies) signaling

  5. Loss of Usp5 (show USP5 Antibodies) results in upregulation of Notch (show NOTCH1 Antibodies) signaling and downregulation of RTK signaling by EGF receptor (EGFR) and Sevenless (Sev), leading to impaired photoreceptor development.

  6. These data demonstrate a strong genetic link between dG9a and the EGFR signaling pathway.

  7. Avermectin directly interacts with EGFR and leads to the activation of the EGFR/AKT (show AKT1 Antibodies)/ERK (show MAPK1 Antibodies) pathway.

  8. The dorsoventral patterning and EGFR signaling genes play essential roles in correct identity determination and differentiation of lateral glia in the Drosophila nervous system.

  9. Data suggest that OSCP1 (organic solute carrier partner 1 (show OSCP1 Antibodies)) plays multiple roles during eye development in D. melanogaster; OSCP1 (show OSCP1 Antibodies) regulates developmental gene expression and epidermal growth factor receptor signaling pathway in imaginal discs of eye.

  10. The vector of cell movement is regulated by localised epidermal growth factor (EGF (show EGF Antibodies)) signalling from the distally placed tip cell lineage and the acquisition of planar polarity leads to asymmetric pulsatile Myosin II accumulation.

Zebrafish Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. Study demonstrated that IGF-I (show IGF1 Antibodies) can stimulate egfr expression in both follicles cell culture and intact follicles promoting oocyte maturation.

  2. These results indicate that maintenance of Pgrmc1 (show PGRMC1 Antibodies) signaling is required for Egfr expression on zebrafish oocyte cell membranes and for conserving the functions of Egfr in maintaining meiotic arrest through estrogen activation of Gper (show GPER Antibodies).

  3. EGFR signaling in vertebrate oocytes can prevent meiotic progression.

  4. the expression of EGFR was mainly restricted to the follicle cells with little expression in the oocytes

Human Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. EGFR and C/EBP-beta (show CEBPB Antibodies) oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-beta (show CEBPB Antibodies) isoform

  2. Studies indicate that positive PD-L1 (show CD274 Antibodies) expression was significantly correlated with KRAS mutation and EGFR mutation.

  3. Piccolo (show PCLO Antibodies) contributes to tumor aggressiveness in esophageal squamous cell carcinoma, likely by stabilizing EGFR and promoting EGFR-dependent signaling.

  4. Finally, the authors show that EGFR-ERK1/2 (show MAPK1/3 Antibodies) and beta1-integrin signaling are the main pathways used for bacteria-mediated EGR1 (show EGR1 Antibodies) upregulation.

  5. Two new signals were observed at genome-wide significance (P < 5 x 10-8), namely, rs7216064 (17q24.3, BPTF (show BPTF Antibodies)), for overall lung adenocarcinoma risk, and rs3817963 (6p21.3, BTNL2 (show BTNL2 Antibodies)) which is specific to cases with EGFR mutations. In further sub-analyses by EGFR status, rs9387478 (ROS1 (show ROS1 Antibodies)/DCBLD1) and rs2179920 (HLA-DPB1 (show HLA-DPB1 Antibodies)) showed stronger estimated associations in EGFR-positive compared to EGFR-negative cases

  6. Study shows that EGFR negatively regulates POPDC1 (show BVES Antibodies) expression in breast cancer cell lines and that overexpression of POPDC1 (show BVES Antibodies) can reduce EGFR-mediated cell migration and proliferation in breast cancer cells.

  7. The present findings indicate that genetic variation in EGFR may contribute to the attainment of extreme old age in Japanese.

  8. developed a simulator to accurately calculate the dynamic sensitivity of extracellular-signal-regulated kinase (ERK (show EPHB2 Antibodies)) activity (ERK (show EPHB2 Antibodies)*) and Akt (show AKT1 Antibodies) activity (Akt (show AKT1 Antibodies)*), downstream of the ErbB receptors stimulated with epidermal growth factor (EGF (show EGF Antibodies)) and heregulin (HRG (show NRG1 Antibodies))

  9. EGFR amplification/EGFRvIII mutation can repress the expression of Pri-miR (show MLXIP Antibodies)-524 by histone modification. MiR (show MLXIP Antibodies)-524-3p and miR (show MLXIP Antibodies)-524-5p inhibited TGF/beta (show TGFB1 Antibodies), Notch (show NOTCH1 Antibodies) and the Hippo pathway by targeting Smad2 (show SMAD2 Antibodies), Hes1 and Tead1 (show TEAD1 Antibodies), respectively; these pathways repressed their common downstream transcription factor, C-myc (show MYC Antibodies).

  10. The searched for functional interactions between EGFR and D2-like receptors, focusing on the molecular mechanisms involved in the EGFR-mediated regulation of dopamine receptor signaling.

Mouse (Murine) Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. EGFR signaling in macrophages, but not in colonic epithelial cells, has a significant role in colitis-associated carcinogenesis.

  2. KrasG12D-driven proliferation of pancreatic ductal epithelial cells (PDECs) depends on an EGFR signaling loop engaging the oncogenic transcription factor c-MYC (show MYC Antibodies).

  3. Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor

  4. High expression of EGFR is associated with lung carcinogenesis.

  5. our results suggest that NeuGcGM3 and EGFR may coordinately contribute to the tumor cell biology and that therapeutic combinations against these two targets might be a valid strategy to explore.

  6. In FGF9-overexpressing colorectal cancer cell lines, FGF9 overexpression induced strong resistance to anti-EGFR therapies via the enforced FGFR (show FGFR2 Antibodies) signal, and this resistance was cancelled by the application of an FGFR (show FGFR2 Antibodies) inhibitor.

  7. Although EGFR activation promotes wound healing, released exosomes may antagonize EGFR activation and wound healing.

  8. opposing signals generated by different ErbB dimer combinations function in the same cardiac cushion mesenchymal cells for proper cardiac valve formation.

  9. Combined targeting of TGF-beta (show TGFB1 Antibodies), EGFR and HER2 (show ERBB2 Antibodies) signaling suppresses lymphangiogenesis and metastasis in a pancreatic ductal adenocarcinoma model.

  10. The conjugation of benzylguanine-modified auristatin F to EGFR-specific 425(scFv)-SNAP and HER2 (show ERBB2 Antibodies)-specific alphaHER2(scFv)-SNAP resulted in two potent recombinant antibody-drug conjugates that specifically killed breast cancer cell lines by inducing apoptosis when applied at nanomolar concentrations.

Pig (Porcine) Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. this study shows that anemonin may ameliorate LPS (show IRF6 Antibodies)-induced intestinal injury and improve restoration by regulating the TGF-b1 and EGFR signaling pathways

  2. Syndecan-4 (show SDC4 Antibodies) mediates porcine respiratory and reproductive syndrome virus entry by interacting with EGFR.

  3. These results indicate that cAMP and oocyte-secreted factors cooperate to promote EGF receptor functionality in developing cumulus oocyte complexes, representing a key component of the acquisition of oocyte developmental competence.

  4. patients experiencing gefitinib dose reduction or short-term treatment interruption due to toxicities did not show inferior survival, compared to those receiving full dose of gefitinib in non-small cell lung cancer patients with EGFR mutation

  5. Report EGFR expression in the normal pancreas.

  6. Injury and activation of purinergic receptors and direct activation of EGFR via EGF (show EGF Antibodies) induce distinct downstream pathways.

  7. Data suggest that the mechanism of hypoxia-induced increased activation of EGFR kinase is mediated by nNOS (show NOS1 Antibodies)-derived nitric oxide.

  8. EGFR, VEGFR (show KDR Antibodies) and FGFR (show FGFR2 Antibodies) are expressed in porcine oviduct and endometrium during the time of implantation [review]

  9. the restricted presence of the functional full-size receptor to the epithelial layer indicates a specific role during early embryonic development, whereas truncated EGF-R forms may potentially regulate contractions and blood flow in the oviduct

  10. The phase-related expression of EGF (show EGF Antibodies) and EGFR in the endothelium of the uterine artery and its branches suggest the modulatory effect of EGF (show EGF Antibodies) and its receptor on the uterine artery and the region supplying these vessels.

Cow (Bovine) Epidermal Growth Factor Receptor (EGFR) interaction partners

  1. Stimulation of bovine oviduct epithelial cell EGFR with EGF (show EGF Antibodies) (human recombinant EGF (show EGF Antibodies)) alone or with EGF (show EGF Antibodies) in postovulatory/follicular phases (not luteal phase) up-regulates phosphorylation of MAPKs; heat blocks effects of EGF (show EGF Antibodies) on phosphorylation of MAPKs.

  2. Expression of the erbB/HER receptor family in the bovine uterus during the sexual cycle and the relation of this family to serum sex steroids.

  3. Regulation of the sperm EGFR by ouabain leads to initiation of the acrosome reaction.

  4. EGFR may simultaneously activate c-Src (show SRC Antibodies) and PI3K to amplify the oxytocin signaling to increase the output of PGF (show PGF Antibodies)(2 alpha) in endometrial epithelial cells.

  5. results indicate that arginase induction depends in part on epidermal growth factor (EGF (show EGF Antibodies)) receptor activity, and that EGFR inhibitors may attenuate vascular remodeling without affecting nitric oxide release

  6. Data suggest that epidermal growth factor (EGF (show EGF Antibodies)) and EGF (show EGF Antibodies) receptors are important paracrine and/or autocrine regulators of spermatogenesis in bovine.

  7. MT1-MMP (show MMP14 Antibodies) has a role in signaling events mediating EGFR transactivation

  8. possible cooperative role of the EGF (show EGF Antibodies) and HGF (show HGF Antibodies) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

  9. EGFR is stimulated during capacitation via PKA activation. More activation induces the acrosome reaction, which is induced by GPCR via EGFR transactivation by a signaling pathway involving PKA, SRC & metalloproteinase & effectors PI3K, PLC & PKC.

EGFR Antigen Profile

Antigen Summary

The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene.

Alternative names and synonyms associated with EGFR

  • epidermal growth factor receptor (EGFR) antibody
  • Epidermal growth factor receptor (Egfr) antibody
  • epidermal growth factor receptor a (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (egfra) antibody
  • epidermal growth factor receptor (egfr1) antibody
  • epidermal growth factor receptor (AaeL_AAEL004319) antibody
  • epidermal growth factor receptor (Egfr) antibody
  • epidermal growth factor receptor (LOC100008806) antibody
  • 9030024J15Rik antibody
  • AI552599 antibody
  • C-erb antibody
  • c-erbB antibody
  • CG10079 antibody
  • D-Egf antibody
  • d-egf-r antibody
  • D-EGFR antibody
  • dEgfr antibody
  • dEGFR1 antibody
  • der antibody
  • DER/EGFR antibody
  • DER/faint little ball antibody
  • DER/top antibody
  • DER/torpedo antibody
  • DER1 antibody
  • DER flb antibody
  • Dmel\\CG10079 antibody
  • DmHD-33 antibody
  • EFG-R antibody
  • Egf antibody
  • Egf-r antibody
  • egfr antibody
  • egfr1 antibody
  • EGFR12 antibody
  • EGFR15 antibody
  • EK2-6 antibody
  • El antibody
  • Elp antibody
  • Elp-1 antibody
  • Elp-B1 antibody
  • Elp-B1RB1 antibody
  • Erbb antibody
  • ErbB-1 antibody
  • ERBB1 antibody
  • Erbb2 antibody
  • Errb1 antibody
  • Errp antibody
  • flb antibody
  • HD-33 antibody
  • HER1 antibody
  • l(2)05351 antibody
  • l(2)09261 antibody
  • l(2)57DEFa antibody
  • l(2)57Ea antibody
  • l(2)57EFa antibody
  • mENA antibody
  • mor1 antibody
  • PIG61 antibody
  • top antibody
  • top/DER antibody
  • top/flb antibody
  • Torpedo/DER antibody
  • torpedo/egfr antibody
  • wa-2 antibody
  • wa2 antibody
  • Wa5 antibody

Protein level used designations for EGFR

CG10079-PA , CG10079-PB , DER-Ellipse , EGF-receptor , EGFR , Egf receptor , Egfr-PA , Egfr-PB , drosophila epidermal growth factor receptor homologue , ellipse , ellipse torpedo , epidermal growth factor receptor , faint little ball , morphological defects 1 , torpedo , torpedo/DER , erbb1a , avian erythroblastic leukemia viral (v-erb-b) oncogene homolog , cell growth inhibiting protein 40 , cell proliferation-inducing protein 61 , proto-oncogene c-ErbB-1 , receptor tyrosine-protein kinase erbB-1 , EGFR-related peptide , Epidermal growth factor receptor formerly avian erythroblastic leukemia viral (v-erbB) oncogene homolog (Erbb1) , avian erythroblastic leukemia viral (v-erbB) oncogene homolog , epidermal growth factor receptor, formerly avian erythroblastic leukemia viral (v-erbB) oncogene homolog (Erbb1) , waved 2 , CER , epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) , egf receptor , receptor tyrosine kinase ErbB1

GENE ID SPECIES
100067755 Equus caballus
37455 Drosophila melanogaster
378478 Danio rerio
778955 Ciona intestinalis
5564544 Aedes aegypti
1956 Homo sapiens
24329 Rattus norvegicus
13649 Mus musculus
396494 Gallus gallus
397070 Sus scrofa
404306 Canis lupus familiaris
407217 Bos taurus
100008806 Oryctolagus cuniculus
100725363 Cavia porcellus
780479 Ovis aries
613027 Macaca mulatta
Selected quality suppliers for anti-EGFR (EGFR) Antibodies
Did you look for something else?